8/15
08:34 am
allo
Allogene Therapeutics, Inc. (NASDAQ: ALLO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Report
Allogene Therapeutics, Inc. (NASDAQ: ALLO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
8/9
06:49 pm
allo
Rating for ALLO
Low
Report
Rating for ALLO
8/9
06:49 pm
allo
Rating for ALLO
Low
Report
Rating for ALLO
8/8
10:16 am
allo
Rating for ALLO
Medium
Report
Rating for ALLO
8/8
10:16 am
allo
Rating for ALLO
Medium
Report
Rating for ALLO
8/8
09:03 am
allo
Allogene Therapeutics, Inc. (NASDAQ: ALLO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $11.00 price target on the stock.
Medium
Report
Allogene Therapeutics, Inc. (NASDAQ: ALLO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $11.00 price target on the stock.
8/8
07:31 am
allo
Rating for ALLO
Medium
Report
Rating for ALLO